These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 30719107)

  • 21. Tropism of mesenchymal stem cell toward CD133
    Pavon LF; Sibov TT; de Souza AV; da Cruz EF; Malheiros SMF; Cabral FR; de Souza JG; Boufleur P; de Oliveira DM; de Toledo SRC; Marti LC; Malheiros JM; Paiva FF; Tannús A; de Oliveira SM; Chudzinski-Tavassi AM; de Paiva Neto MA; Cavalheiro S
    Stem Cell Res Ther; 2018 Nov; 9(1):310. PubMed ID: 30413179
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Heterogeneous phenotype of human glioblastoma: in vitro study.
    Denysenko T; Gennero L; Juenemann C; Morra I; Masperi P; Ceroni V; Pragliola A; Ponzetto A; Melcarne A
    Cell Biochem Funct; 2014 Mar; 32(2):164-76. PubMed ID: 23836332
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Preliminary interpretation on the relationship between the phenotype of CD133+ cells and niche in transplanted human glioma in mice].
    Song WC; Fei XF; Dong J
    Zhonghua Zhong Liu Za Zhi; 2010 Aug; 32(8):564-9. PubMed ID: 21122405
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cell division patterns and chromosomal segregation defects in oral cancer stem cells.
    Kaseb HO; Lewis DW; Saunders WS; Gollin SM
    Genes Chromosomes Cancer; 2016 Sep; 55(9):694-709. PubMed ID: 27123539
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Glioblastoma specific antigens, GD2 and CD90, are not involved in cancer stemness.
    Woo SR; Oh YT; An JY; Kang BG; Nam DH; Joo KM
    Anat Cell Biol; 2015 Mar; 48(1):44-53. PubMed ID: 25806121
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of CD133/prominin-1 antisense oligodeoxynucleotide on in vitro growth characteristics of Huh-7 human hepatocarcinoma cells and U251 human glioma cells.
    Yao J; Zhang T; Ren J; Yu M; Wu G
    Oncol Rep; 2009 Oct; 22(4):781-7. PubMed ID: 19724856
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cucurbitacin I inhibits tumorigenic ability and enhances radiochemosensitivity in nonsmall cell lung cancer-derived CD133-positive cells.
    Hsu HS; Huang PI; Chang YL; Tzao C; Chen YW; Shih HC; Hung SC; Chen YC; Tseng LM; Chiou SH
    Cancer; 2011 Jul; 117(13):2970-85. PubMed ID: 21225866
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dedifferentiation of patient-derived glioblastoma multiforme cell lines results in a cancer stem cell-like state with mitogen-independent growth.
    Olmez I; Shen W; McDonald H; Ozpolat B
    J Cell Mol Med; 2015 Jun; 19(6):1262-72. PubMed ID: 25787115
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sox21 inhibits glioma progression in vivo by forming complexes with Sox2 and stimulating aberrant differentiation.
    Caglayan D; Lundin E; Kastemar M; Westermark B; Ferletta M
    Int J Cancer; 2013 Sep; 133(6):1345-56. PubMed ID: 23463365
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Engagement of cellular prion protein with the co-chaperone Hsp70/90 organizing protein regulates the proliferation of glioblastoma stem-like cells.
    Iglesia RP; Prado MB; Cruz L; Martins VR; Santos TG; Lopes MH
    Stem Cell Res Ther; 2017 Apr; 8(1):76. PubMed ID: 28412969
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cancer stem cell analysis and clinical outcome in patients with glioblastoma multiforme.
    Pallini R; Ricci-Vitiani L; Banna GL; Signore M; Lombardi D; Todaro M; Stassi G; Martini M; Maira G; Larocca LM; De Maria R
    Clin Cancer Res; 2008 Dec; 14(24):8205-12. PubMed ID: 19088037
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detection of CD133 expression in U87 glioblastoma cells using a novel anti-CD133 monoclonal antibody.
    Wang D; Guo Y; Li Y; Li W; Zheng X; Xia H; Mao Q
    Oncol Lett; 2015 Jun; 9(6):2603-2608. PubMed ID: 26137114
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The extracellular matrix niche microenvironment of neural and cancer stem cells in the brain.
    Reinhard J; Brösicke N; Theocharidis U; Faissner A
    Int J Biochem Cell Biol; 2016 Dec; 81(Pt A):174-183. PubMed ID: 27157088
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CD133 as a marker for regulation and potential for targeted therapies in glioblastoma multiforme.
    Choy W; Nagasawa DT; Trang A; Thill K; Spasic M; Yang I
    Neurosurg Clin N Am; 2012 Jul; 23(3):391-405. PubMed ID: 22748652
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Coexpression analysis of CD133 and CD44 identifies proneural and mesenchymal subtypes of glioblastoma multiforme.
    Brown DV; Daniel PM; D'Abaco GM; Gogos A; Ng W; Morokoff AP; Mantamadiotis T
    Oncotarget; 2015 Mar; 6(8):6267-80. PubMed ID: 25749043
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Resveratrol targeting of AKT and p53 in glioblastoma and glioblastoma stem-like cells to suppress growth and infiltration.
    Clark PA; Bhattacharya S; Elmayan A; Darjatmoko SR; Thuro BA; Yan MB; van Ginkel PR; Polans AS; Kuo JS
    J Neurosurg; 2017 May; 126(5):1448-1460. PubMed ID: 27419830
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Production of interleukin‑4 in CD133+ cervical cancer stem cells promotes resistance to apoptosis and initiates tumor growth.
    Liu CT; Xin Y; Tong CY; Li B; Bao HL; Zhang CY; Wang XH
    Mol Med Rep; 2016 Jun; 13(6):5068-76. PubMed ID: 27121303
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Glioblastoma Multiforme Cancer Stem Cells Express Components of the Renin-Angiotensin System.
    Bradshaw AR; Wickremesekera AC; Brasch HD; Chibnall AM; Davis PF; Tan ST; Itinteang T
    Front Surg; 2016; 3():51. PubMed ID: 27730123
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Astrocyte Elevated Gene-1 Regulates β-Catenin Signaling to Maintain Glioma Stem-like Stemness and Self-Renewal.
    Hu B; Emdad L; Kegelman TP; Shen XN; Das SK; Sarkar D; Fisher PB
    Mol Cancer Res; 2017 Feb; 15(2):225-233. PubMed ID: 27903708
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Primary glioblastoma cultures: can profiling of stem cell markers predict radiotherapy sensitivity?
    Lemke D; Weiler M; Blaes J; Wiestler B; Jestaedt L; Klein AC; Löw S; Eisele G; Radlwimmer B; Capper D; Schmieder K; Mittelbronn M; Combs SE; Bendszus M; Weller M; Platten M; Wick W
    J Neurochem; 2014 Oct; 131(2):251-64. PubMed ID: 24976529
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.